Evidence map›Paper›PMID 29779582›Full record

ReviewBest practice & research. Clinical endocrinology & metabolism2018

Animal models of endocrine disruption.

Heather B Patisaul, Suzanne E Fenton, David Aylor

Open access · greenAbstract readReview
In one paragraph

Review in Best practice & research. Clinical endocrinology & metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Impact of Endocrine Disruptors upon Non-Genetic Inheritance.International journal of molecular sciences · 2022
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. In Vitro Effects of Emerging Bisphenols on Myocyte Differentiation and Insulin Responsiveness.Toxicological sciences : an official journal of the Society of Toxicology · 2020
    Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Heather B PatisaulCenter for Human Health and the Environment, W.M. Keck Center for Behavioral Biology, Department of Biological Sciences, North Carolina State University, Raleigh, NC, 27695, USA. Electronic address: hbpatisa@ncsu.edu.
Suzanne E FentonDivision of the National Toxicology Program (DNTP), NTP Laboratory, National Institute of Environmental Health Sciences (NIEHS), National Institute of Health (NIH), Research Triangle Park, NC, 27709, USA. Electronic address: suzanne.fenton@nih.gov.
David AylorCenter for Human Health and the Environment, Bioinformatics Research Center, W.M. Keck Center for Behavioral Biology, Department of Biological Sciences, North Carolina State University, Raleigh, NC, 27695, USA. Electronic address: dlaylor@ncsu.edu.
North Carolina State University · USNational Institute of Environmental Health Sciences · US

Funding

Mammary Gland as a Sensitive End Point to Effects of Endocrine DisruptorsZIAES102785 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI FENTON, SUZANNE · 2010 to 2021
$38.1M
Translational Research Support CoreP30ES025128 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Sue Fenton · 2015 to 2026
$18.3M
Systems Toxicogenomics of Endocrine Disrupting Chemicals in BrainU01ES026717 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI AYLOR, DAVID LAWRENCE · 2016 to 2019
$2.9M
Epigenetics, environmental exposure, and reproduction in the Collaborative CrossR00ES021535 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI AYLOR, DAVID LAWRENCE · 2014 to 2016
$723k
NIEHS NIH HHS P30 ES025128NIEHS NIH HHS R00 ES021535NIEHS NIH HHS U01 ES026717
6 · The paper itself

Abstract

Endocrine disrupting chemicals (EDCs) are compounds that alter the structure and function of the endocrine system and may be contributing to disorders of the reproductive, metabolic, neuroendocrine and other complex systems. Typically, these outcomes cannot be modeled in cell-based or other simple systems necessitating the use of animal testing. Appropriate animal model selection is required to effectively recapitulate the human experience, including relevant dosing and windows of exposure, and ensure translational utility and reproducibility. While classical toxicology heavily relies on inbred rats and mice, and focuses on apical endpoints such as tumor formation or birth defects, EDC researchers have used a greater diversity of species to effectively model more subtle but significant outcomes such as changes in pubertal timing, mammary gland development, and social behaviors. Advances in genomics, neuroimaging and other tools are making a wider range of animal models more widely available to EDC researchers.

Indexed as

Disease Models, AnimalEndocrine System DiseasesAnimalsEndocrine DisruptorsEndocrine SystemEnvironmental ExposureEnvironmental IllnessHumansReproducibility of ResultsReproductionEndocrine Disruptorscollaborative crossneurosciencesperomyscusPFOAtoxicologyvole

Identifiers

PMID29779582
PMCPMC6029710
OpenAlexW2795408627

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.